Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-060671)

Filing Details

Accession Number:: 0001209191-22-060671
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-12 16:02:51
Reporting Period:: 2022-12-08

Accepted Time:: 2022-12-12 16:02:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1822711	Pardes Biosciences Inc.	PRDS	Pharmaceutical Preparations (2834)	852696306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1884733	P. Sean Brusky	C/O Pardes Biosciences, Inc. 2173 Salk Ave., Suite 250, Pmb #052 Carlsbad CA 92008	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-08	21,000	$1.19	21,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.15 to $1.20. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.